JPMorgan: Not overly concerned about the impact of rising interest rates on China's healthcare sector, and remains bullish on biotechnology and CXO services.

JPMorgan released a report stating that, as global interest rates—particularly the yields on 10-year and 30-year U.S. Treasuries—rise, the risk-free rate used in its DCF model and the stock valuations based on DCF are under greater pressure than before. Consequently, the firm has reassessed the potential impact of interest rates on Chinese healthcare valuations, especially within the biotechnology and CXO subsectors. If a higher risk-free rate is adopted in the DCF analysis, companies such as Insilico Medicine (03696.HK) in the AIDD space, GenScript (01548.HK) and Wuxi Apptec (02359.HK) in the CXO sector, and Junshi Biosciences (018…

AASTOCKSOct 6 10:19

Hong Kong Stock Market Movers | Xuanzhu Bio-B (02575) surges 20% in afternoon trading; the company had previously announced preliminary discussions regarding a potential acquisition.

Xuanzhu Bio-B (02575) surged 20% in the afternoon. As of press time, it was up 19.75% at HK$9.7, with a turnover of HK$48.4758 million. Zhitong Finance APP learned that Xuanzhu Bio-B (02575) surged 20

Zhitong FinanceSep 29 13:37

GF Securities: Initiates coverage of Sihuan Pharmaceutical with a "Buy" rating; fair value estimated at HKD 1.11 per share

Guangfa Securities released a research report stating that it is initiating coverage of Sihuan Pharmaceutical (00460) and assigning a "Buy" rating. The firm forecasts the company's revenue to reach

Sina FinanceSep 23 11:13

Selected HKEX Announcements | Cathay Pacific's Passenger Load Increases by Over 10% in First Eight Months; Maifushi Raises Funds Through Share Placement to Expand Token Factory

① Cathay Pacific's passenger traffic rose by more than 10% in the first eight months—how did it perform in August alone? ② MicroStrategy is raising capital through a rights issue to expand its token‑

CLSSep 17 21:17

Zhitong HK Stock Market Analysis | AI Pharma News Gains Momentum Amid Expectations of a Modest Fed Rate Hike

Market performance was fairly solid, with U.S. stocks falling only modestly as expected, while Hong Kong stocks edged down 0.44%. [Anatomy Overview]After a three-year hiatus, the Federal Reserve has

Zhitong FinanceSep 17 19:52

Xuanzhu Bio-B (02575): Abnormal stock price volatility; preliminary discussions underway with a party regarding a potential acquisition

Xuanzhu Bio-B (02575) announced that the company's Board of Directors has noted a rise in the price of the company's H shares today. After conducting all reasonable inquiries, the Board confirms

Zhitong FinanceSep 17 19:49